Skip to main content

Name
Caitlyn Vlasschaert

Tue, 11/10/2020 - 13:36

It was both helpful & inspiring to hear from a newly established physician-scientist this past week. Dr. Richard-Carpentier succinctly presented several ongoing efforts in translational hematology-- from characterizing AML-causing mutations to developing (& re-purposing) drugs to target the disease. I particularly enjoyed learning about his transition to independent research and how his professional relationships within the Leucegene network (https://leucegene.ca/) have grown from mentorship to collaboration. The local medical & research community is certainly very lucky that Dr. Richard-Carpentier decided to set up shop at Queen's.

Thanks also to my colleague Melinda for leading the discussion ever so eloquently. Your communication skills are seriously impressive.

Name
Caitlyn Vlasschaert

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.